24
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1040 |
Calcitonin (salmon)
鲑降钙素,Calcitonin salmon,Salmon calcitonin |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Calcitonin (salmon) 是一种阿米林和卡西宁受体的双激动剂,是一种钙调节激素,能够刺激骨的生成并能抑制骨吸收。 | |||
T17194 |
Ubrogepant
MK-1602 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Ubrogepant (MK-1602) 是新型的、口服有效的降钙素基因相关肽受体拮抗剂。Ubrogepant 有潜力用于急性偏头痛的相关研究。 | |||
T12293L |
Olcegepant
BIBN-4096,BIBN 4096BS |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Olcegepant (BIBN-4096) 是一种选择性的降钙素基因相关肽1 (CGRP1) 受体拮抗剂,IC50=0.03 nM,Ki=14.4 pM。 | |||
T8682 |
Vazegepant hydrochloride
Vazegepant HCl |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Vazegepant hydrochloride (Vazegepant HCl) 是一种用于偏头痛的鼻用 gepant,是一种高度亲和性CGRP 受体拮抗剂 (hCGRPKi=0.023 nM)。它可能有助于有效管理 COVID-19 相关肺部炎症。 | |||
T4610 |
Rimegepant
BMS 927711,BMS-927711,BMS927711,BHV-3000 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Rimegepant (BMS 927711) 是一种有效的降钙素基因相关肽 (CGRP) 受体拮抗剂 (Ki=0.027 nM,IC50=0.14 nM)。Rimegepant 可同时用于偏头痛急性发作治疗及预防性治疗。 | |||
T6590 |
MK-3207 Hydrochloride
MK-3207 HCl |
CGRP Receptor | GPCR/G Protein; Neuroscience |
MK-3207 Hydrochloride (MK-3207 HCl) 是口服具有活力的CGRP receptor 拮抗剂,IC50=0.12 nM,Ki=0.024 nM。 | |||
TP1200 |
CGRP (83-119), rat TFA
Calcitonin Gene Related Peptide(83-119), rat TFA |
Others | Others |
CGRP (83-119), rat TFA (Calcitonin Gene Related Peptide(83-119), rat TFA) 是一种由 37 个氨基酸组成的神经肽降钙素家族,通过降钙素受体样受体起作用。 | |||
TP1134L |
HCGRP-(8-37) acetate
HCGRP-(8-37) acetate (119911-68-1 free base) |
CGRP Receptor | GPCR/G Protein; Neuroscience |
HCGRP-(8-37) acetate 是一种人降钙素基因相关肽 (hCGRP) 片段醋酸盐,也是 CGRP 受体的拮抗剂。 | |||
T38734 |
Vazegepant
Zavegepant,BHV-3500,BMS-742413 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Vazegepant (Zavegepant) 是一种可口服且具有选择的降钙素基因相关肽 CGRP 受体拮抗剂,可缓解疼痛,可用于研究偏头疼。 | |||
T26682 |
Atogepant
MK 8031,MK8031. Atogepant,MK-8031 |
Others | Others |
Atogepant is an antagonist of calcitonin gene-related peptide receptor. | |||
T39522 |
HTL22562
|
Others | Others |
HTL22562 is a calcitonin gene-related peptide (CGRP) receptor antagonist for acute treatment of migraine. | |||
TP1203 |
CGRP(83-119), rat
Calcitonin Gene Related Peptide (CGRP) (83-119), rat |
||
Calcitonin Gene Related Peptide (CGRP) (83-119), rat is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor. | |||
T12293 |
Olcegepant hydrochloride
BIBN-4096 hydrochloride,BIBN4096BS hydrochloride |
Others | Others |
Olcegepant hydrochloride is a potent and selective non-peptidethe calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (with IC50 of 0.03 nM for human CGRP). | |||
TP2044 |
α-CGRP(human)
α-CGRP (human) |
||
Endogenous calcitonin gene-related peptide receptor (CGRP) agonist. | |||
T26796 |
BI-44370
|
Others | Others |
BI-44370, a CGRP (calcitonin gene-related peptide) receptor antagonist, can be used to treat migraines and other chronic pain. | |||
T70248 |
4991W93
|
Others | Others |
4991W93 is a 5HT(1B/1D) receptor partial agonist, inhibiting electrically induced plasma extravasation, blocking neurogenic plasma protein extravasation, inhibiting release of calcitonin gene-related peptide. | |||
T16093 |
Telcagepant
MK-0974 |
Others | Others |
Telcagepant is an orally active antagonist of calcitonin gene-related peptide (CGRP) receptor (Kis: 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively). | |||
T76363 |
[Tyr22] Calcitonin Gene Related Peptide, (22-37), rat
|
||
[Tyr22]CalcitoninGene Related Peptide, (22-37), rat 是一种大鼠降钙素基因相关肽 (CGRP) 的 22-37 片段,靶向CGRP 受体和腺苷酸环化酶。降钙素 (calcitonin) 主要由甲状腺 C 细胞产生,而 CGRP 则分泌并储存在神经系统中。 | |||
TP1625 |
Adrenomedullin (11-50), rat
|
||
Adrenomedullin 11-50 rat is a peptide fragment of adrenomedullin that possesses systemic vasodilator activity at the level of calcitonin gene-related peptide-1 (CGRP1) receptor activation. Adrenomedullin and its peptide may be used in bone growth studies. | |||
TP2049 |
CRSP-1
|
||
Endogenous central calcitonin (CT) receptor agonist that stimulates cAMP formation at a potency 350-fold greater than CT (ED50 values are 0.2 and 71 nM respectively). Displays no activity at calcitonin-gene related peptide (CGRP) and adrenomedullin recept | |||
T73703 |
(3R,5R,6S)-Atogepant
|
Others | Others |
(3R,5R,6S)-Atogepant ((3R,5R,6S)-MK-8031) 是Atogepant 的异构体.Atogepant 是降钙素基因相关肽受体 (CGRP) 拮抗剂。Atogepant 可用于研究偏头痛。 | |||
T37413 |
Calcitonin (salmon) (trifluoroacetate salt)
|
Others | Others |
Calcitonin is a peptide hormone that lowers blood calcium level and inhibits bone resorption. It belongs to the calcitonin family of peptides, which also includes amylin , calcitonin gene-related peptide , and adrenomedullin. The binding of salmon calcitonin to the human calcitonin receptor (CTR) is not modulated by receptor activity-modifying proteins (RAMPs), which influence affinity of human calcitonin to CTR. Salmon calcitonin binds to human CTR2 with IC50 values of 0.933, 0.224, 0.134, and ... | |||
T76678 | Eptinezumab | ||
Eptinezumab为人源化单克隆抗体,主要通过与降钙素基因相关肽(CGRP)结合,进而阻止其与受体相结合,用于成人偏头痛的预防。 | |||
TP2049L |
CRSP-1 acetate(697327-12-1 Free base)
|
||
CRSP-1 acetate(697327-12-1 Free base) 是一种内源性中枢降钙素(CT)受体激动剂,其刺激cAMP形成的效力是CT的350倍(ED50值分别为0.2和71nM)。CRSP-1 acetate 对降钙素基因相关肽 (CGRP) 和肾上腺髓质素受体没有活性。CRSP-1 acetate 抑制多核破骨细胞的形成,其体外功效与CT相似。CRSP-1 acetate 抑制自由进食大鼠的食物摄入并升高体温,并显着降低体内血浆钙水平。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-03280 |
RAMP3 Protein, Human, Recombinant (hFc)
receptor (G protein-coupled) activity modifying pro... |
Human | HEK293 Cells |
RAMP3 belongs to the RAMP family. Members of this family are single-transmembrane-domain proteins, called receptor (calcitonin) activity modifying proteins (RAMPs). RAMPs have a wide biological distribution; high concentrations are found in the brain, lung, liver, heart and spleen with lower expression levels present in the testes, gastrointestinal tract and thyroid. RAMPs are type I transmembrane proteins with an extracellular N terminus and a cytoplasmic C terminus. They are required to transp... | |||
TMPY-02839 |
Adrenomedullin Protein, Human, Recombinant (hFc)
AM,PAMP,adrenomedullin |
Human | HEK293 Cells |
Adrenomedullin consists of 52 amino acids and is a member of the adrenomedullin family. It s a a hypotensive peptide and has 1 intramolecular disulfide bond. It seems that adrenomedullin has a slight homology with the calcitonin gene-related peptide. Adrenomedullin has a highly expression in pheochromocytoma and adrenal medulla. It also can be detected in lung, ventricle and kidney tissues. Adrenomedullin and PAMP are potent hypotensive and vasodilatator agents. Numerous actions have been report... | |||
TMPK-01491 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,HBV,Hepatitis B virus |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01501 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Tetramer Protein, Human, MHC (His & Avi)
MHC,Hepatitis B virus,HBV |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01505 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi), Biotinylated
E7,MHC,HPV16 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01492 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi)
Hepatitis B virus,HBV,MHC |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01504 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer Protein, Human, MHC (His & Avi)
MHC,HPV16,E7 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01506 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi)
HPV16,E7,MHC |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. |